PROTEOVANT
Live / Registered — Registered (as of 01 Aug 2023)
What this means for you
Registered since 01 Aug 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90858111
- Registration number
- 7123854
- Mark type
- Stylized text
- Filed
- 30 Jul 2021
- Published for opposition
- 16 May 2023
- Registered
- 01 Aug 2023
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use comprising small molecules for degrading disease-causing cellular proteins for prevention and treatment of oncological, allergy and immunological, neurological, cardiac, dermatological, endocrinological, gastroenterological, hematological, infectious, genetic, nephrological, gynecological, ophthalmological, orthopedic, otorhinolaryngological, podiatric, psychiatric, pulmonological, respiratory, rheumatological, and urological diseases and disorders; biologic preparations for medical and therapeutic purposes comprising small molecules for degrading disease-causing cellular proteins for prevention and treatment of oncological, allergy and immunological, neurological, cardiac, dermatological, endocrinological, gastroenterological, hematological, infectious, genetic, nephrological, gynecological, ophthalmological, orthopedic, otorhinolaryngological, podiatric, psychiatric, pulmonological, respiratory, rheumatological, and urological diseases and disorders; pharmaceutical and biological preparations for treatment and prevention of cancer and for the treatment and prevention of auto-immune diseases and disorders and central nervous system and neurological diseases and disorders
- Class 042 — Scientific and technological services: Pharmaceutical product development for new small molecules aimed at degrading disease-causing cellular proteins for treatment in the field of oncology; scientific and technological services, namely, medical research, scientific research and analysis in the field of pharmaceuticals and biomedicine; pharmaceutical and biomedical research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and biomedicine
- Class 044 — Medical, beauty and agricultural services: Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions
Owner
- Roivant Sciences GmbH, Basel, CH
- Roivant Sciences GmbH, Basel, CH
- Roivant Sciences GmbH, Basel, CH
Prosecution history
- 01 Aug 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 01 Aug 2023 — REGISTERED-PRINCIPAL REGISTER
- 16 May 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 May 2023 — PUBLISHED FOR OPPOSITION
- 26 Apr 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Apr 2023 — ELECTRONIC RECORD REVIEW COMPLETE
- 07 Apr 2023 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 03 Apr 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Mar 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Mar 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 Mar 2023 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 28 Feb 2023 — NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
- 28 Feb 2023 — ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
- 28 Feb 2023 — ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
- 15 Feb 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED